| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/09/2007 | EP1783218A1 Hcv rna having novel sequence |
| 05/09/2007 | EP1783217A1 Stabilized proline transporter |
| 05/09/2007 | EP1783216A1 Telomerase-inhibitory ena oligonucleotide |
| 05/09/2007 | EP1783215A1 Angiostatin and method of use for inhibition of angiogenesis |
| 05/09/2007 | EP1783214A1 Mutant glycoprotein not modified with asparagine-linked sugar chain |
| 05/09/2007 | EP1783212A1 Methods of adenovirus purification |
| 05/09/2007 | EP1783209A1 Selective culture method and separation method for small hepatocytes with the use of hyaluronic acid |
| 05/09/2007 | EP1783203A1 Process for producing substances |
| 05/09/2007 | EP1783142A1 Mouse monoclonal antibody recognizing acetyllysine, labeled antibody and utilization of the same |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1783135A1 Automatable method for preparing samples which can be universally applied |
| 05/09/2007 | EP1782838A1 Inhibition of infiltration, and cell killing agent |
| 05/09/2007 | EP1782822A1 Remedy for melaonoma |
| 05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
| 05/09/2007 | EP1782061A1 Method for redesign of microbial production systems |
| 05/09/2007 | EP1781823A2 In vivo assays for modulation of smad-mediated signaling |
| 05/09/2007 | EP1781819A1 Cytochrome p450 induction assay |
| 05/09/2007 | EP1781802A2 Production of a tnfr-ig fusion protein |
| 05/09/2007 | EP1781796A2 Targeted transgenesis of short hairpin rna expression cassettes using recombinase mediated cassette exchange |
| 05/09/2007 | EP1781795A2 Methods of protecting plants from pathogenic fungi |
| 05/09/2007 | EP1781794A2 Genetic loci associated with fusarium solani tolerance in soybean |
| 05/09/2007 | EP1781793A2 Reduced susceptibility towards pathogens, in particular comycetes, such as downy mildew in lettuce and spinach |
| 05/09/2007 | EP1781792A2 Retinal dystrophin transgene and methods of use thereof |
| 05/09/2007 | EP1781791A2 Hemopexin fusion proteins |
| 05/09/2007 | EP1781790A2 Alpha-amylase variants with altered properties |
| 05/09/2007 | EP1781789A2 Thymidine kinase |
| 05/09/2007 | EP1781788A2 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 05/09/2007 | EP1781787A2 Treatment of eye disorders characterized by an elevated intraocular pressure by sirnas |
| 05/09/2007 | EP1781786A2 Method of error reduction in nucleic acid populations |
| 05/09/2007 | EP1781785A1 Methods of producing mutant polynucleotides |
| 05/09/2007 | EP1781784A2 Method for isolation of transcription termination sequences |
| 05/09/2007 | EP1781783A2 Method of in vitro polypeptide selection using the arc dna binding domain fused to the polypeptide to be selected |
| 05/09/2007 | EP1781782A1 Modified vitamin k dependent polypeptides |
| 05/09/2007 | EP1781781A2 Nucleic acid sequences encoding cel ii endonuclease |
| 05/09/2007 | EP1781702A2 Nucleoproteins displaying native t cell receptor libraries |
| 05/09/2007 | EP1781690A2 Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics |
| 05/09/2007 | EP1781682A1 B7-h5, a costimulatory polypeptide |
| 05/09/2007 | EP1781681A2 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 05/09/2007 | EP1781593A2 Cationic lipids and methods of use |
| 05/09/2007 | EP1781338A2 Modulation of cytokine signaling regulators and applications for immunotherapy |
| 05/09/2007 | EP1781337A2 Methods and compositions for cell activation |
| 05/09/2007 | EP1781332A1 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 05/09/2007 | EP1781094A1 Transgenic non-human animal for use in research models for studying parkinson's disease |
| 05/09/2007 | EP1781083A2 Brassica indehiscent1 sequences |
| 05/09/2007 | EP1781082A2 Biological gene transfer system for eukaryotic cells |
| 05/09/2007 | EP1781081A1 Aluminium tolerant barley |
| 05/09/2007 | EP1731530A9 A kind of fusion protein, gene encoding it, expression method and use thereof |
| 05/09/2007 | EP1656450A4 Cephalosporin c acylase mutant and method for preparing 7-aca using same |
| 05/09/2007 | EP1616033A4 Dna polymerase fusions and uses thereof |
| 05/09/2007 | EP1601769B1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism |
| 05/09/2007 | EP1601768B1 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 05/09/2007 | EP1573031A4 Androgen regulated nucleic acid molecules and encoded proteins |
| 05/09/2007 | EP1543125B1 Enone reductase gene and microbial production of levodione |
| 05/09/2007 | EP1504105B1 Wound-inducible expression in plants |
| 05/09/2007 | EP1478759B1 Retroviral vectors pseudotyped with influenza virus hemagglutinin and influenza m2 potein for gene delivery |
| 05/09/2007 | EP1456663B1 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 05/09/2007 | EP1366197B1 Methods and compositions for amplification of rna sequences |
| 05/09/2007 | EP1365788B1 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 05/09/2007 | EP1363714A4 A microchip electrospray device and column with affinity adsorbents and use of the same |
| 05/09/2007 | EP1356116B1 Hybridization buffers using low molecular weight dextran sulfate and methods for their use |
| 05/09/2007 | EP1338651B9 Method of screening remedy for diabetes |
| 05/09/2007 | EP1327000B1 Transposon mediated multiplex sequencing |
| 05/09/2007 | EP1313882B1 Diagnosis and treatment of prostate cancer |
| 05/09/2007 | EP1254169B1 Methods relating to modulation of th2 cell subset activity by modulation of xbp-1 activity |
| 05/09/2007 | EP1212431B1 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 05/09/2007 | EP1196634B1 Method for identifying a compound that modulates the function of the gene product of an essential gene |
| 05/09/2007 | EP1180143B1 In vitro methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues, pharmaceutical compositions related thereto |
| 05/09/2007 | EP1169058B1 Insulin-like growth factor binding protein-4 protease |
| 05/09/2007 | EP1140968B9 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 05/09/2007 | EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 05/09/2007 | EP1012244B1 Rhabdoviruses with reengineered coats |
| 05/09/2007 | EP1005553B1 Secretion of carrier-bonded proteins into the periplasma and the extracellular space |
| 05/09/2007 | EP1000149B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 05/09/2007 | EP0998486B1 Protein recovery by chromatography followed by filtration upon a charged layer |
| 05/09/2007 | EP0967275B1 Dna sequences enhancing promoter activity |
| 05/09/2007 | EP0960212B1 Gene identification method |
| 05/09/2007 | EP0871734B1 Polypeptide fragments capable of competition with streptococcus mutans antigen i/ii |
| 05/09/2007 | EP0868535B9 Methods and compositions for determining the sequence of nucleic acid molecules |
| 05/09/2007 | EP0793675B9 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/09/2007 | EP0782625B1 Expression and export technology of proteins as immunofusins |
| 05/09/2007 | EP0716706B9 Method of production of transgenic plants wholly transformed into t o? generation, from meristems |
| 05/09/2007 | EP0692029B1 Genetically engineered glutaminase and its use in therapy |
| 05/09/2007 | CN1961075A Therapeutic molecules for modulating stability of VEGF transcripts |
| 05/09/2007 | CN1961074A Polynucleotide associated with a type II diabetes comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for analyzing polynucleotide using the same |
| 05/09/2007 | CN1961073A Truncated DANCE, DANCE complex and method of using these |
| 05/09/2007 | CN1961072A Improved nitrile hydratase |
| 05/09/2007 | CN1961071A Methods and constructs for expressing polypeptide polymers in eukaryotic cells using alternative splicing |
| 05/09/2007 | CN1961070A Recombinantly modified plasmin |
| 05/09/2007 | CN1961002A Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/09/2007 | CN1961001A Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins |
| 05/09/2007 | CN1960825A Functionalized colloidal metal compositions and methods |
| 05/09/2007 | CN1960767A Potent mucosal immune response induced by modified immunomodulatory oligonucleotides |
| 05/09/2007 | CN1960757A Composition for increasing body height |
| 05/09/2007 | CN1960707A Liposomal assembly for therapeutic and/or diagnostic use |
| 05/09/2007 | CN1958810A Method for detecting CVM deleterious gene of oxen |
| 05/09/2007 | CN1958803A Method for constructing genome integral recombined viral vector related to gland |
| 05/09/2007 | CN1958802A Plant gene expression carrier, and application |
| 05/09/2007 | CN1958801A Method for constructing interference plasmid of human fibrinogen hf12 shRNA, and pharmic usage |
| 05/09/2007 | CN1958800A Method for extracting plasmid DNA, and extraction device |